MedaSystems launches platform update

MedaSystems announced the release of Version 3.3 of its SaaS platform for managing Expanded Access, Post-Trial Access and Investigator-Initiated Study programs. The update introduces new capabilities to help pharmaceutical and biotechnology organizations manage patient access programs with greater efficiency, consistency and control.